{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T06:30:53Z","timestamp":1786516253541,"version":"build-2736575974"},"reference-count":66,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T00:00:00Z","timestamp":1786492800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Metabolic dysfunction-associated steatotic liver disease (MASLD) is a heterogeneous liver disease involving metabolic dysfunction, inflammatory activity, immune activation, and fibrotic remodeling. Immune-inflammatory biomarkers and immune-related features may support disease characterization, fibrosis assessment, and risk stratification, but the knowledge structure of this subfield remains unclear. This study used bibliometric methods to map the development, contributors, intellectual structure, and emerging trends of immune-inflammatory biomarker and immune-feature research in MASLD\/NAFLD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Publications were retrieved from the Web of Science Core Collection (WoSCC), with Scopus used for cross-database validation. After manual screening and data refinement, 268 WoSCC publications from 2000 to 2025 were retained for primary analysis. CiteSpace and VOSviewer were used to analyze publication trends, contributing countries, institutions, journals, authors, collaboration networks, keyword co-occurrence, keyword bursts, and reference co-citation clusters.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Annual publication output increased markedly after 2022. China contributed the largest number of publications, whereas the United States showed the strongest collaborative link strength. Aarhus University was the leading institution, while Henning Gr\u00f8nb\u00e6k and Konstantin Kazankov were the leading authors by publication output. Co-citation and keyword analyses indicated that the field is organized around overlapping domains, including systemic inflammatory indices, hepatic inflammation and histologic injury, immune-cell and macrophage-centered features, fibrosis assessment, treatment-response readouts, and prognostic stratification. Recent keyword bursts highlighted oxidative stress, macrophages, pathogenesis, and liver fibrosis. Scopus validation showed broadly consistent temporal and thematic patterns.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>Overall, this subfield is rapidly expanding toward fibrosis-oriented stratification, immune-cell phenotyping, and clinically scalable inflammatory biomarker research.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2026.1896838","type":"journal-article","created":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T05:56:03Z","timestamp":1786514163000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Immune-inflammatory biomarkers and immune features in metabolic dysfunction-associated steatotic liver disease: a bibliometric study"],"prefix":"10.3389","volume":"17","author":[{"given":"Zelin","family":"Ye","sequence":"first","affiliation":[{"name":"Department of Infection, Guang\u2019anmen Hospital, China Academy of Chinese Medical Sciences","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingrui","family":"Liu","sequence":"additional","affiliation":[{"name":"Data Center of Traditional Chinese Medicine, China Academy of Chinese Medical Sciences","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingjuan","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Infection, Guang\u2019anmen Hospital, China Academy of Chinese Medical Sciences","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiuchong","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Infection, Guang\u2019anmen Hospital, China Academy of Chinese Medical Sciences","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenliang","family":"Lyu","sequence":"additional","affiliation":[{"name":"Department of Infection, Guang\u2019anmen Hospital, China Academy of Chinese Medical Sciences","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,12]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2023.06.003","article-title":"A multisociety delphi consensus statement on new fatty liver disease nomenclature","volume":"79","author":"Rinella","year":"2023","journal-title":"J Hepatol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1097\/HEP.0000000000000004","article-title":"The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review","volume":"77","author":"Younossi","year":"2023","journal-title":"Hepatology"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.numecd.2016.01.011","article-title":"Insulin resistance, postprandial GLP-1 and adaptive immunity are the main predictors of NAFLD in a homogeneous population at high cardiovascular risk","volume":"26","author":"Bozzetto","year":"2016","journal-title":"Nutr Metab Cardiovasc Dis NMCD"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.634409","article-title":"Controversies and opportunities in the use of inflammatory markers for diagnosis or risk prediction in fatty liver disease","volume":"11","author":"Lambrecht","year":"2020","journal-title":"Front Immunol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2021.07.025","article-title":"TVB-2640 (FASN inhibitor) for the treatment of nonalcoholic steatohepatitis: FASCINATE-1, a randomized, placebo-controlled phase 2a trial","volume":"161","author":"Loomba","year":"2021","journal-title":"Gastroenterology"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2024.2304157","article-title":"Disruption of gut barrier integrity and host\u2013microbiome interactions underlie MASLD severity in patients with type-2 diabetes mellitus","volume":"16","author":"Forlano","year":"2024","journal-title":"Gut Microbes"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3350\/cmh.2022.0205","article-title":"Single-cell phenotypes of peripheral blood immune cells in early and late stages of non-alcoholic fatty liver disease","volume":"29","author":"Waller","year":"2023","journal-title":"Clin Mol Hepatol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1080\/14728222.2022.2132145","article-title":"Spotlight on liver macrophages for halting injury and progression in nonalcoholic fatty liver disease","volume":"26","author":"Laursen","year":"2022","journal-title":"Expert Opin Ther Targets"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2020.108626","article-title":"Dynamic shifts in the composition of resident and recruited macrophages influence tissue remodeling in NASH","volume":"34","author":"Daemen","year":"2021","journal-title":"Cell Rep"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1337241","article-title":"Systemic immune-inflammatory biomarkers (SII, NLR, PLR and LMR) linked to non-alcoholic fatty liver disease risk","volume":"15","author":"Liu","year":"2024","journal-title":"Front Immunol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2024.1415484","article-title":"Association of systemic immune biomarkers with metabolic dysfunction-associated steatotic liver disease: a cross-sectional study of NHANES 2007-2018","volume":"11","author":"Wang","year":"2024","journal-title":"Front Nutr"},{"key":"B12","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1186\/s12933-025-03011-0","article-title":"Plasma inflammatory proteome profiles identify MASLD among children with overweight or obesity","volume":"24","author":"Wang","year":"2025","journal-title":"Cardiovasc Diabetol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1038\/s42255-019-0076-1","article-title":"Transcriptional network analysis implicates altered hepatic immune function in NASH development and resolution","volume":"1","author":"Haas","year":"2019","journal-title":"Nat Metab"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1002\/hep.26937","article-title":"The portal inflammatory infiltrate and ductular reaction in human nonalcoholic fatty liver disease","volume":"59","author":"Gadd","year":"2014","journal-title":"Hepatology"},{"key":"B15","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1186\/s40064-015-1542-1","article-title":"Global publication trends and research hotspots of nonalcoholic fatty liver disease: a bibliometric analysis and systematic review","volume":"4","author":"Zhang","year":"2015","journal-title":"SpringerPlus"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1007\/s10238-023-01023-2","article-title":"A bibliometric analysis and visualization of nonalcoholic fatty liver disease from 2012 to 2021","volume":"23","author":"Li","year":"2023","journal-title":"Clin Exp Med"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1121540","article-title":"Global publication trends and research hotspots of the gut-liver axis in NAFLD: a bibliometric analysis","volume":"14","author":"Yang","year":"2023","journal-title":"Front Endocrinol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e24187","article-title":"A bibliometric analysis of macrophages associated with non-alcoholic fatty liver disease research from 2005 to 2023","volume":"10","author":"Yang","year":"2024","journal-title":"Heliyon"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1007\/s11192-009-0146-3","article-title":"Software survey: VOSviewer, a computer program for bibliometric mapping","volume":"84","author":"van Eck","year":"2010","journal-title":"Scientometrics"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0307513100","article-title":"Searching for intellectual turning points: progressive knowledge domain visualization","author":"Chen","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1111\/jgh.12943","article-title":"Macrophage activation marker soluble CD163 and non-alcoholic fatty liver disease in morbidly obese patients undergoing bariatric surgery","volume":"30","author":"Kazankov","year":"2015","journal-title":"J Gastroenterol Hepatol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1111\/liv.13150","article-title":"The macrophage activation marker sCD 163 is associated with morphological disease stages in patients with non-alcoholic fatty liver disease","volume":"36","author":"Kazankov","year":"2016","journal-title":"Liver Int"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinre.2024.102393","article-title":"The pan immune inflammatory value in relation to non-alcoholic fatty liver disease and hepatic fibrosis","volume":"48","author":"Jiang","year":"2024","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2024.1491858","article-title":"Association between neutrophil-to-high-density lipoprotein cholesterol ratio and non-alcoholic fatty liver disease or metabolic dysfunction-associated steatotic liver disease: evidence from NHANES 2017\u20132020","volume":"11","author":"Zhu","year":"2025","journal-title":"Front Med"},{"key":"B25","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1186\/s12876-024-03394-6","article-title":"Association between neutrophil-to-high-density lipoprotein cholesterol ratio and metabolic dysfunction-associated steatotic liver disease and liver fibrosis in the US population: a nationally representative cross-sectional study using NHANES data from 2017 to 2020","volume":"24","author":"Lu","year":"2024","journal-title":"BMC Gastroenterol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1186\/s41043-025-00926-y","article-title":"Neutrophil percentage-to-albumin ratio and neutrophil-to-albumin ratio as novel biomarkers for non-alcoholic fatty liver disease: a systematic review and meta-analysis","volume":"44","author":"El-Sehrawy","year":"2025","journal-title":"J Health Popul Nutr"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1007\/s10238-024-01539-1","article-title":"The association between immunoinflammatory biomarkers NLR, PLR, LMR and nonalcoholic fatty liver disease: a systematic review and meta-analysis","volume":"25","author":"Yang","year":"2025","journal-title":"Clin Exp Med"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2015-010342","article-title":"Association between white blood cell count and non-alcoholic fatty liver disease in urban han chinese: a prospective cohort study","volume":"6","author":"Wang","year":"2016","journal-title":"BMJ Open"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3390\/metabo16010025","article-title":"Associations between systemic inflammatory markers, metabolic dysfunction, and liver fibrosis scores in patients with MASLD","volume":"16","author":"Eid","year":"2025","journal-title":"Metabolites"},{"key":"B30","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1186\/s12876-025-03778-2","article-title":"High sensitivity C-reactive protein implicates heterogeneous metabolic phenotypes and severity in metabolic dysfunction associated-steatotic liver disease","volume":"25","author":"Wang","year":"2025","journal-title":"BMC Gastroenterol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s12963-025-00378-w","article-title":"NPR is an independent risk factor for predicting all-cause mortality in patients with metabolic dysfunction-associated steatotic liver disease: evidence from NHANES 2007\u20132020","volume":"23","author":"Ye","year":"2025","journal-title":"Popul Health Metrics"},{"key":"B32","doi-asserted-by":"publisher","first-page":"30403","DOI":"10.1038\/s41598-024-80801-8","article-title":"Predictive role of neutrophil percentage-to-albumin ratio, neutrophil-to-lymphocyte ratio, and systemic immune-inflammation index for mortality in patients with MASLD","volume":"14","author":"Dong","year":"2024","journal-title":"Sci Rep"},{"key":"B33","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1186\/s12876-025-03924-w","article-title":"The role of C-reactive protein to lymphocyte ratio in NAFLD and mortality among NAFLD patients","volume":"25","author":"Xi","year":"2025","journal-title":"BMC Gastroenterol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.708959","article-title":"Crosstalk between plasma cytokines, inflammation, and liver damage as a new strategy to monitoring NAFLD progression","volume":"12","author":"Fontes-Cal","year":"2021","journal-title":"Front Immunol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1002\/hep4.1068","article-title":"Association between cytokines and liver histology in children with nonalcoholic fatty liver disease","volume":"1","author":"Perito","year":"2017","journal-title":"Hepatol Commun"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0143380","article-title":"Peripheral and hepatic vein cytokine levels in correlation with non-alcoholic fatty liver disease (NAFLD)-related metabolic, histological, and haemodynamic features","volume":"10","author":"Vonghia","year":"2015","journal-title":"PloS One"},{"key":"B37","doi-asserted-by":"publisher","first-page":"49","DOI":"10.3892\/ijmm.2012.965","article-title":"Markers of activated inflammatory cells correlate with severity of liver damage in children with nonalcoholic fatty liver disease","volume":"30","author":"De Vito","year":"2012","journal-title":"Int J Mol Med"},{"key":"B38","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1164\/rccm.201307-1339OC","article-title":"Obstructive sleep apnea syndrome affects liver histology and inflammatory cell activation in pediatric nonalcoholic fatty liver disease, regardless of obesity\/insulin resistance","volume":"189","author":"Nobili","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-011-9571-1","article-title":"Altered phenotype and functionality of circulating immune cells characterize adult patients with nonalcoholic steatohepatitis","volume":"31","author":"Inzaugarat","year":"2011","journal-title":"J ClinImmunol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2014.01.010","article-title":"Serum immunoglobulin levels predict fibrosis in patients with non-alcoholic fatty liver disease","volume":"60","author":"McPherson","year":"2014","journal-title":"J Hepatol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.18.20012","article-title":"Pilot study to diagnose nonalcoholic steatohepatitis with Dynamic18 F-FDG PET","volume":"212","author":"Sarkar","year":"2019","journal-title":"Am J Roentgenol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.3350\/cmh.2020.0261","article-title":"Serum lipocalin-2 is a potential biomarker for the clinical diagnosis of nonalcoholic steatohepatitis","volume":"27","author":"Xu","year":"2021","journal-title":"Clin Mol Hepatol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1038\/ctg.2015.36","article-title":"Circulating soluble CD163 is associated with steatohepatitis and advanced fibrosis in nonalcoholic fatty liver disease","volume":"6","author":"Mueller","year":"2015","journal-title":"Clin Transl Gastroenterol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1016\/j.gastha.2023.03.006","article-title":"Obese patients with nonalcoholic fatty liver disease have an increase in soluble plasma CD163 and a concurrent decrease in hepatic expression of CD163","volume":"2","author":"Skytthe","year":"2023","journal-title":"Gastro Hep Adv"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1097\/MPG.0000000000002111","article-title":"Macrophage markers are poorly associated with liver histology in children with nonalcoholic fatty liver disease","volume":"67","author":"Kazankov","year":"2018","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2020.616212","article-title":"Macrophage markers do not add to the prediction of liver fibrosis by transient elastography in patients with metabolic associated fatty liver disease","volume":"7","author":"Kazankov","year":"2020","journal-title":"Front Med"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1111\/hepr.13071","article-title":"Formation of p62-positive inclusion body is associated with macrophage polarization in non-alcoholic fatty liver disease","volume":"48","author":"Fukushima","year":"2018","journal-title":"Hepatol Res"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.92902","article-title":"CD11c+ resident macrophages drive hepatocyte death-triggered liver fibrosis in a murine model of nonalcoholic steatohepatitis","volume":"2","author":"Itoh","year":"2017","journal-title":"JCI Insight"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexmp.2015.06.015","article-title":"Fat-laden macrophages modulate lobular inflammation in nonalcoholic steatohepatitis (NASH)","volume":"99","author":"Jindal","year":"2015","journal-title":"Exp Mol Pathol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2019-318382","article-title":"Myeloid cells in liver and bone marrow acquire a functionally distinct inflammatory phenotype during obesity-related steatohepatitis","volume":"69","author":"Krenkel","year":"2020","journal-title":"Gut"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2021.103233","article-title":"Single-cell RNA transcriptome landscape of hepatocytes and non-parenchymal cells in healthy and NAFLD mouse liver","volume":"24","author":"Su","year":"2021","journal-title":"iScience"},{"key":"B52","doi-asserted-by":"publisher","first-page":"e0643","DOI":"10.1097\/HC9.0000000000000643","article-title":"Single-cell landscape of peripheral immune cells in MASLD\/MASH","volume":"9","author":"Steixner-Kumar","year":"2025","journal-title":"Hepatol Commun"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2024.101564","article-title":"Monocyte bioenergetics: an immunometabolic perspective in metabolic dysfunction-associated steatohepatitis","volume":"5","author":"Sangineto","year":"2024","journal-title":"Cell Rep Med"},{"key":"B54","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1002\/hep4.1041","article-title":"Hepatic natural killer T-cell and CD8+ T-cell signatures in mice with nonalcoholic steatohepatitis","volume":"1","author":"Bhattacharjee","year":"2017","journal-title":"Hepatol Commun"},{"key":"B55","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s13293-023-00569-w","article-title":"Sex-based differences in natural killer T cell-mediated protection against diet-induced steatohepatitis in balb\/c mice","volume":"14","author":"Cu\u00f1o-G\u00f3miz","year":"2023","journal-title":"Biol Sex Differ"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1290391","article-title":"Role of the co-stimulatory molecule inducible T-cell co-stimulator ligand (ICOSL) in the progression of experimental metabolic dysfunction-associated steatohepatitis","volume":"14","author":"Provera","year":"2023","journal-title":"Front Immunol"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.563434","article-title":"A mineralocorticoid receptor deficiency in myeloid cells reduces liver steatosis by impairing activation of CD8+ T cells in a nonalcoholic steatohepatitis mouse model","volume":"11","author":"Mu\u00f1oz-Durango","year":"2020","journal-title":"Front Immunol"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1093\/clinchem\/hvae208","article-title":"Performance of noninvasive tests for metabolic dysfunction-associated steatohepatitis and liver fibrosis resolution after bariatric surgery","volume":"71","author":"Angelini","year":"2025","journal-title":"Clin Chem"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2022.100661","article-title":"Effect of pegbelfermin on NASH and fibrosis-related biomarkers and correlation with histological response in the FALCON 1 trial","volume":"5","author":"Brown","year":"2023","journal-title":"JHEP Rep"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.3390\/antiox12040833","article-title":"Mediterranean diet improves plasma biomarkers related to oxidative stress and inflammatory process in patients with non-alcoholic fatty liver disease","volume":"12","author":"Quetglas-Llabr\u00e9s","year":"2023","journal-title":"Antioxidants"},{"key":"B61","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.jpeds.2019.07.037","article-title":"The contribution of the adipose tissue-liver axis in pediatric patients with nonalcoholic fatty liver disease after laparoscopic sleeve gastrectomy","volume":"216","author":"Franchitto","year":"2020","journal-title":"J Pediatr"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23126696","article-title":"Combined therapy with a CCR2\/CCR5 antagonist and FGF21 analogue synergizes in ameliorating steatohepatitis and fibrosis","volume":"23","author":"Puengel","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1111\/bph.16378","article-title":"A long-acting FGF21 attenuates metabolic dysfunction-associated steatohepatitis-related fibrosis by modulating NR4A1-mediated Ly6C phenotypic switch in macrophages","volume":"181","author":"Ji","year":"2024","journal-title":"Br J Pharmacol"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1038\/s41401-024-01389-3","article-title":"SGLT2 inhibitors ameliorate NAFLD in mice via downregulating PFKFB3, suppressing glycolysis and modulating macrophage polarization","volume":"45","author":"Lin","year":"2024","journal-title":"Acta Pharmacol Sin"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1172\/JCI154333","article-title":"Myeloid FoxO1 depletion attenuates hepatic inflammation and prevents nonalcoholic steatohepatitis","volume":"132","author":"Lee","year":"2022","journal-title":"J Clin Invest"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1111\/apt.17995","article-title":"Hepatic inflammation and fibrosis are profiles related to mid-term mortality in biopsy-proven MASLD: a multicenter study in Japan","volume":"59","author":"Tsutsumi","year":"2024","journal-title":"Aliment Pharmacol Ther"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1896838\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T05:56:04Z","timestamp":1786514164000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1896838\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,12]]},"references-count":66,"alternative-id":["10.3389\/fimmu.2026.1896838"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1896838","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,12]]},"article-number":"1896838"}}